Truist Financial Corp Buys 14,770 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Truist Financial Corp lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 38.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 52,887 shares of the financial services provider’s stock after purchasing an additional 14,770 shares during the period. Truist Financial Corp owned 0.11% of iShares Biotechnology ETF worth $6,992,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $30,000. HHM Wealth Advisors LLC raised its stake in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $33,000. Finally, Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $138.91 on Friday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The stock’s fifty day simple moving average is $135.61 and its 200 day simple moving average is $140.77.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.